Viral Infections Transmitted through Tissue TRANSPLANTATION

Sterilisation of Tissues Using Ionising Radiations

Volumn , Issue , 2005, Pages 255-278

  Eastlund, Ted ^a,b  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b Fairview University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33747873625     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1533/9781845690779.4.255     Document Type: Chapter

References (117)

1. Strong D.M. The US Navy tissue bank: fifty years on the cutting edge. Cell Tissue Banking 2000, 1:9-16.
2. McLean V.A. Standards For Tissue Banking 2001, American Association of Tissue Banks (AATB).
3. European Association of Tissue Banks (EATB) Standards For Tissue Banking 2000, Berlin, Germany.
4. Eye Bank Association of America (EBAA) Medical Standards 2002, Washington, DC, USA.
5. United Network for Organ Sharing (UNOS) Cadaveric Donors and Cadaveric Organ Transplantation In The US. UNOS Update 2001, 10(29).
6. Office of the Inspector General Oversight of Tissue Banking 2001, 1-17. US Department of Health and Human Services, Boston, MA, USA.
7. Choo Y., Eastlund T. Tissue transplantation and HLA typing. Tissue Cell Report 1996, 3:2-3.
8. Eastlund T. The histo-blood group ABO system and tissue transplantation. Transfusion 1998, 38:975-988.
9. Gottesdiener K.M. Transplanted infections: donor to host transmission with the allograft. Ann. Intern. Med 1989, 110:1001-1010.
10. Eastlund T. Infectious disease transmission through cell, tissue and organ transplantation: reducing the risk through donor selection. Cell Transplant 1995, 4:455-477.
11. Goode S.M., Hertzmark E., Steinert R.F. Accuracy of the ELISA test for screening corneal transplant donors. Am. J. Ophthalmol 1988, 106:463-466.
12. Cantrill H.L., Henry K., Jackson B., Erice A., Ussery F.M., Balfour H.H. Recovery of human immunodeficiency virus from ocular tissues in patients with acquired immune deficiency syndrome. Ophthalmology 1988, 95:1458-1462.
13. Fujikawa L.S., Salahuddin S.Z., Ablashi D., Palestine A.G., Masur H., Nussenblatt R.B., Gallo R.C. Human T-cell leukemia/lymphotropic virus type III in the conjunctival epithelium of a patient with AIDS. Am. J. Ophthalmol 1985, 100:507-509.
14. Fujikawa L.S., Salahuddin S.Z., Palestine A.G., Masur H., Nussenblatt R.B., Gallo R.C. Isolation of human T -lymphotropic virus type III from the tears of a patient with the acquired immunodeficiency syndrome. Lancet 1985, 2:529-530.
15. Heck E., Petty C., Palestine A., Luckenbach M., Salahuddin S.Z., Nussenblatt R., Harris W. ELISA HIV testing and viral culture in the screening of corneal tissue for transplant from medical examiner case. Cornea 1989, 8:77-80.
16. Salahuddin S.Z., Palestine A.G., Heck E., Ablashi D., Luckenbach M., McCulley J.P., Nussenblatt R.B. Isolation of the human T-cell leukemia/lymphotropic virus type III from the cornea. Am. J. Ophthalmol 1986, 101:149-152.
17. Pepose J.S., Macrae S., Quinn T.C., Ward J.W. Serologic markers after transplantation of corneas from donors infected with human immunodeficiency virus. Am. J. Ophthalmol 1987, 103:798-801.
18. Schwarz A., Hoffman F., L'Age-Stehr J., Tegzess A.M., Offermann G. Human immunodeficiency virus transmission by organ donation: outcome in cornea and kidney recipients. Transplantation 1987, 44:21-24.
19. Raber I.M., Friedman H.M. Hepatitis B surface antigen in corneal donors. Am. J. Ophthalmol 1987, 104:255-258.
20. Khalil A., Ayoub M., Abdel-Wahab S.E-D., El-Salakawy A. Assessment of the infectivity of corneal buttons taken from Hepatitis B surface antigen seropositive donors. Brit. J. Ophthal 1995, 79:6-9.
21. Sengler V., Reinhard T., Adams O., Gerlich W., Sundmacher R. Testing of corneoscleral discs and their culture media of seropositive donors for hepatitis B and C virus genomes. Graefes Arch. Clin. Exper. Ophthal 2001, 239:783-787.
22. O'Day D.M. Diseases potentially transmitted through corneal transplantation. Ophthalmology 1989, 96:1133-1138.
23. Hoft R.H., Pflugfelder S.C., Forster R.L., Ullman S., Polack F.M., Schiff E.R. Clinical evidence for hepatitis B transmission resulting from corneal transplantation. Cornea 1997, 16:132-137.
24. Koch F.J., Sagartz J.W., Davidson D.E., Lawhaswasdi K. Diagnosis of human rabies by the cornea test. Am. J. Clin. Path 1975, 63:509-515.
25. Gode G.R., Bhide N.K. Two rabies deaths after corneal grafts from one donor. Lancet 1988, 2:791.
26. Centre for Disease Control Human to human transmission of rabies by a corneal transplant - Idaho. MMWR 1979, 28:109-111.
27. Centre for Disease Control Human to human transmission of rabies by a corneal transplant - France. MMWR 1980, 29:25-26.
28. Centre for Disease Control Human to human transmission of rabies by a corneal transplant - Thailand. MMWR 1981, 30:473-474.
29. Houff S.A., Burton R.C., Wilson R.W., Henson T.E., London W.T., Baer G.M., Anderson L.J., Winkler W.G., Madden D.L., Sever J.L. Human to human transmission of rabies virus by corneal transplant. N. Engl. J. Med 1979, 300:603-604.
30. Baer G.M., Shaddock J.H., Houff S.A., Harrison A.K., Gardner J.J. Human rabies transmitted by cornea transplant. Arch. Neurol 1982, 39:103-107.
31. Javadi M.A., Fayaz A., Mirdehghans A., Ainollahi B. Transmission of rabies by cornea graft. Cornea 1996, 15:431-433.
32. Holland E.J., Bennett S.R., Brannian R., Osborne J.C., Goeken J.A., Krachmer J.H. The risk of cytomegalovirus transmission by penetrating keratoplasty. Am. J. Ophthalmol 1988, 105:357-360.
33. Cleator G.M., Klapper P.E., Dennett C., Sullivan A.L., Bonshek R.E., Marcyniuk B., Tullo A.B. Corneal donor infection by herpes simplex virus: herpes simplex virus DNA in donor corneas. Cornea 1994, 13:294-304.
34. Tullo A.B., Marcyniuk B., Bonshek R., Dennett C., Cleator G.M., Lewis A.G., Klapper P.E. Herpes virus in a corneal donor. Eye 1990, 4:766-767.
35. Shurkin N.M. Homologous serum hepatitis following the use of refrigerated bone bank bone. J. Bone Joint Surg 1954, 36A:160-162.
36. Eggen B.M., Nordbo S.A. Transmission of HCV by organ transplantation. N. Engl. J. Med 1992, 326:411.
37. Pereira B.J., Milford E.L., Kirkman R.L., Levey A.S., Tomford W.W., Leibowitz H., Rhodes M., Quan S., Wilbur J.C. Low risk of liver disease after tissue transplantation from donors with HCV. Lancet 1993, 341:903-904.
38. Conrad E.U., Gretch D., Obermeyer K., Moogk M., Sayers M., Wilson J., Strong D.M. The transmission of hepatitis C virus by tissue transplantation. J. Bone Joint Surg 1995, 77-A:214-224.
39. Tugwell B.D., Patel P.R., Williams I.T., Thomas A., Homan H., Hedberg K., Cieslak P.R. Hepatitis C virus (HCV) transmission to tissue and organ recipients from an antibody negative donor - United States, 42nd. Ann. Interscience Conf. Antimicrob. Agents Chemother. (ICAAC) 2002, San Diego, CA, USA, LB-17.
40. Centre for Disease Control Hepatitis C virus transmission from an antibody-negative organ and tissue donor - United States, 2001-2002. MMWR 2003, 5:273-276.
41. Petersen L.R., Simons R.J., Koistinen J. HIV transmission through blood, tissue and organs. AIDS 1993, 7:99-107.
42. Simonds R.J., Holmberg S.D., Hurwitz R.L., Coleman T.R., Bottenfield S., Conley L.J., Kohlenberg S.H., Castro K.G., Dahan B.A., Schable C.A., et al. Transmission of human immunodeficiency virus type 1 from a seronegative organ and tissue donor. N. Engl. J. Med 1992, 326:726-732.
43. Buck B.E., Resnick L., Shah S.M., Malinin T.I. Human immunodeficiency virus cultured from bone. Implications for transplantation. Clin. Orthop. Rel. Res 1990, 251:250-253.
44. Merz H., Rytik G., Muller W.E.G., Roder W. Bestimmung einer HIV infektion in menschlinchen Knochen. Unfallchirurg 1991, 94:47-49.
45. Nyberg M., Suni J., Haltia M. Isolation of human immunodeficiency virus (HIV) at autopsy one to six days postmortem. Am. J. Clin. Pathol 1990, 94:422-425.
46. Marthy S., Richter M. Human immunodeficiency virus activity in rib allografts. J. Oral Maxillofacial Surg 1998, 56:474-476.
47. Centre for Disease Control Transmission of HIV through bone transplantation: case report and public health recommendations. MMWR 1988, 37:587-599.
48. Schratt H.E., Regel G., Kiesewetter B., Tscherne H. HIV infection caused cold preserved bone transplants. Unfallchirung 1996, 99:679-684.
49. Li C.M., Ho Y.R., Liu Y.C. Transmission of human immunodeficiency virus through bone transplantation: a case report. J. Formosan Med. Assoc 2001, 100:350-351.
50. Bowen P.A., Lobel S.A., Caruanna R.J., Leffell M.S., House M.A., Rissing J.P., Humphries A.L. Transmission of human immunodeficiency virus (HIV) by transplantation: clinical aspects and time course analysis of viral antigenemia and antibody production. Ann. Intern. Med 1988, 108:46-48.
51. Horsburgh C.R., Ou C.Y., Jason J., Holmberg S.D., Longini I.M., Schable C., Mayer K.H., Lifson A.R., Schochetman G., Ward J.W., et al. Duration of human immunodeficiency virus infection before detection of antibody. Lancet 1989, 2:637-640.
52. Petersen L.R., Satten G.A., Dodd R., Busch M., Kleinman S., Grindon A., Lenes B. Duration of time from onset of human immunodeficiency virus type 1 infectiousness to development of detectable antibody. Transfusion 1994, 34:283-289.
53. Nowicki M.J. Reevaluation of anti-HIV seroprevalence among blood donors with contemporary screening assays. Transfusion 1992, 32:S32.
54. Stramer S.L., Heller J.S., Coombs R.W., Parry J.V., Ho D.D., Allain J.P. Markers of HIV infection prior to IgG antibody seropositivity. JAMA 1989, 262:64-69.
55. Zaaijer H.L., Exel-Oehlers P., Kraaijeveld T., Altena E., Lelie P.N. Early detection of HIV-1 by third generation assay. Lancet 1992, 340:770-772.
56. Busch M.P. HIV and blood transfusions: focus on seroconversion. Vox Sang 1994, 62(S3):13-18.
57. Busch M.P., Lee L.L.L., Satten G.A., Henrard D.R., Farzadegan H., Nelson K.E., Read S., Dodd R.Y., Petersen L.R. Time course of detection of viral and serological markers preceding human immunodeficiency virus type 1 seroconversion: implications for screening blood and tissue donors. Transfusion 1995, 35:91-97.
58. Stramer S.L., Cagliotti S., Strong D.M. NAT of the United States and Canadian blood supply. Transfusion 2000, 50:1165-1168.
59. Hamilton J., Eastlund T., Steckler D., Prather J., Dodd R. Low Prevalence of human immunodeficiency virus seropositivity in surgical bone donors. A survey of 20 regional surgical bone banks. 14th Annual Meeting, American Association of Tissue Banks 1990, Denver, CO, USA.
60. Scofield C., Eastlund T., Steckler D., Larson M., Schuller R., Petersen J. Prevalence of infectious disease markers in surgical bone donors, 17th Annual Meeting 1993, American Association of Tissue Banks, Boston, MA, USA.
61. Scofield C., Eastlund T., Larson N., Steckler D., Metcalfe J., Korent H. Retesting of 1,608 living tissue donors for HIV and HCV. An evaluation of results. 17th Annual Meeting, American Association of Tissue Banks 1993, Boston, MA, USA.
62. Eastlund T., Strong D.M., Mowe J. The prevalence of infectious disease markers in cadaveric tissue donors: 1992 AATB survey results and a review. 18th Annual Meeting 1994, American Association of Tissue Banks, San Francisco, CA, USA.
63. McLean V.A. Annual Registration Survey of Accredited Tissue Banks 2000, American Association of Tissue Banks (AATB).
64. Schreiber G.B., Glynn S.A., Domesyn M.A., Wright D.J., Tu Y., Dodd R.Y., Murphy E.L. Lapsed donors: an untapped resource. Transfusion 2003, 43:17-24.
65. Asselmeier M.A., Caspari R.B., Bottenfield S.A. Review of allograft processing and sterilization techniques and their role in transmission of human immunodeficiency virus. Am. J. Sports Med 1993, 21:170-217.
66. Buck B.E., Malinin T.I., Brown M.D. Bone transplantation and human immunodeficiency virus; an estimate of risk of acquired immunodeficiency syndrome (AIDS). Clin. Orthop 1989, 240:129-136.
67. Carlson E.R., Marx R.E., Buck B.E. The potential for HIV transmission through allogeneic bore. A review of risks and safety. Oral Surg. Oral Med. Oral Path 1995, 80:17-23.
68. Sanzen L., Carlsson A. Transmission of human T-cell lymphotrophic virus-type I by a deep-frozen bone allograft. Acta Orthop. Scand 1997, 68:72-74.
69. Donald P.J., Cole A. Cartilage implantation in head and neck surgery: report of a national survey. Otolaryngol. Head Neck Surg 1982, 90:85-89.
70. Noyes F.R., Barber S.D., Mangine R.E. Bone patellar ligament-bone and fascia lata allografts for reconstruction of the anterior cruciate ligament. J. Bone Joint Surg 1990, 72A:1125-1136.
71. Buck B.E., Malinin T.I. Human bone and tissue allografts. Clin. Orthop 1994, 303:8-17.
72. Standards of the American Red Cross Tissue Services 1994, American Red Cross Tissue Services, Washington, DC, USA. 6th Edition. D. Campagnari, J. O'Malley (Eds.).
73. Food and Drug Administration (FDA) Human tissue intended for transplantation: US Department of Health and Human Services, Rockville, Maryland, 21 CFR 1270. Federal Register 1993, 58:65514-65521.
74. Food and Drug Administration (FDA) Human tissue intended for transplantation: US Department of Health and Human Services, Rockville, Maryland, 21 CFR 1270. Federal Register 1997, 62:40429-40447.
75. Food and Drug Administration (FDA) Suitability determination for donors of human cellular and tissue-based products, US Department of Health and Human Services, 21 CFR Part 1271. Federal Register 1999, 64:52696-52723.
76. Morris A., Strickett M.G., Barratt-Boyes B.G. Use of aortic valve allografts from hepatitis B surface antigen positive donors. Ann. Thorac. Surg 1990, 49:802-805.
77. Thijssen E.J., Kroes A.C., Box E., Persijn G.G., Rothbarth P.H. The significance of complete serological testing for hepatitis B in heart valve banking. Transplantation 1993, 56:82-84.
78. Blajchman M., Feinman S., Bull S. Results of a prospective randomized multicenter trial to evaluate the non-A, non-B surrogate tests (ALT and anti-HBc) to prevent post transfusion hepatitis. Blood 1993, 81:S1. 204A.
79. Roth W.K., Weber M., Petersen D., Drosten C., Buhr S., Sereis W., Weichert W., Hedges D., Seifried C. NAT for HBV and anti-HBc testing increase blood safety. Transfusion 2002, 42:869-875.
80. Berger R., Gartner S., Rappersberger K., Foster C.A., Wolff K., Stingl G. Isolation of human immunodeficiency type 1 from human epidermis: viral replication and transmission studies. J. Invest. Dermatol 1992, 99:271-277.
81. Gala J.L., Vandenbroucke A.T., Vandercam B., Pirnay J.P., Delferriere N., Burtonboy G. HIV-1 detection by nested PCR and viral culture in fresh and cryopreserved postmortem skin: potential implications for skin handling and allografting. J. Clin. Path 1997, 50:481-484.
82. Kanitakis J., Escach S., Trepo C., Thivolet J. Detection of human immunodeficiency virus - DNA and RNA in the skin of HIV-infected patients using the polymerase chain reaction. J. Invest. Dermatol 1991, 97:91-96.
83. Clarke J.A. HIV transmission and skin grafts. Lancet 1987, 1:983.
84. Van Baare J., Mackie D.P., Middelkoop E. HIV transmission by transplant of allograft skin: a review of the literature. Burns 1997, 23:460.
85. Pirnay J.P., Vandenvelde C., Duinslaeger L., Reper P., Vanderkelen A. HIV transmission by transplantation of allograft skin: a review of the literature. Burns 1997, 23:1-5.
86. Abecassis M., Kaufman D., Stuart F. Direct evidence that murine cytomegalovirus (CMV) can be transferred via skin grafting using novel oligonucleotides in the polymerase chain reaction (PCR). 19th Annual Meeting 1993, American Society of Transplant Surgeons, Houston, TX., USA.
87. Abecassis M. Transmission of CMV by skin allografts - a review. Tissue Cell Rep 1994, 2:15-20.
88. Shelby J., Shanley J. Transfer of murine cytomegalovirus by syngereic skin grafts. Transplantation 1987, 44:318-320.
89. Shelby J., Saffle J.R., Kern E.R. Transmission of cytomegalovirus infection in mice by skin graft. J. Trauma 1998, 28:203-206.
90. Kealey G.P., Bale J.F., Strauss R.G., Massanari R.M. Cytomegalovirus infection in burn patients. J. Burn Care Rehabil 1987, 8:543-545.
91. Cederna P., Bale J.F., Strauss R., Kealey G.P. Transmission of cytomegalovirus infection by cadaveric allograft in burn patients. 24th Annual Meeting 1994, American Burn Association, Salt Lake City, UT, USA, A143.
92. Chamberland M.E. Emerging infectious agents: do they pose a risk to the safety of transfused blood and blood products?. Clin. Infect. Dis 2002, 34:797-805.
93. Strong D.M., Katz L. Blood-bank testing for infectious diseases: how safe is blood transfusion?. Trends Mol. Med 2002, 8:355-358.
94. Centre for Disease Control, Provisional surveillance summary of the West Nile Virus epidemic - United States, January - November, 2002. MMWR 2002, 51:1129-1133.
95. Centre for Disease Control, Update. Outbreak of severe acute respiratory syndrome-worldwide, 2003. MMWR 2003, 52:241-248.
96. Peters T.G. Life or death. The issue of payments in cadaveric organ donation. JAMA 1991, 269:1302-1305.
97. Eastlund T. Monetary blood donation incentives and the risk of transfusion-transmitted infection. Transfusion 1998, 38:874-882.
98. Markris M., Garson J.A., Ring C.J., Tuke P.W., Tedden R.N., Preston F.E. Hepatitis C virus RNA in clotting factor concentrates and the development of hepatitis in recipients. Blood 1993, 81:1898-1902.
99. Centre for Disease Control, Semen banking, organ and tissue transplantation, and HIV antibody testing. MMWR 1988, 37:57-63.
100. Centre for Disease Control and Prevention, Guidelines for preventing transmission of human immunodeficiency virus through transplantation of human tissue and organ. MMWR 1994, 43:1-17.
101. Alter H.J., Epstein J.S., Swenson S.G., Van Raden M.J., Ward J.W., Kaslow R.A., Menitove J.E., Klein H.G., Sandler S.G., Sayers M.H. Prevalence of human immunodeficiency virus type 1 p24 antigen in US blood donors - an assessment of the efficacy of testing in donor screening. N. Engl. J. Med 1990, 323:1312-1317.
102. Busch M.P., Taylor P.E., Lenes B.A., Kleinman S.H., Stuart M., Stevens C.E., Tomasulo P.A., Allain J.P., Hollingsworth C.G., Mosley J.W. Screening of selected male blood donors for p24 antigen of human immunodeficiency virus type 1. N. Engl. J. Med 1990, 323:1308-1312.
103. Harrell J., McCreedy B., Johnston A. PCR vs p24 antigen testing for detection of HIV-1 in cadaveric blood specimens. 17th Annual Meeting 1993, American Association of Tissue Banks, Boston, MA, USA.
104. Pepose J.S., Buerger D.G., Paul D.A., Quinn T.C., Darragh T.M., Donegan E. New developments in serologic screening of corneal donors for HIV-1 and hepatitis B virus infections. Ophthalmology 1992, 99:879-888.
105. Malhotra R., Morgan D.A. p24 antigen screening to reduce the risk of HIV transmission by seronegative bone allograft donors. National Med. J. India 2001, 13:190-192.
106. Yotsuyanagi H., Yasuda K., Meriya K., Shintani Y., Fujie H., Tsutsumi T., Norjiri N., Juji T., Hoshino H., Shimoda K., Hiro K., Ilino S., Koike K. Frequent presence of HBV in the sera of HBsAg-negative anti-HBC-positive blood donors. Transfusion 2001, 41:1093-1099.
107. Wang J., Lee C., Chen P., Wang T., Chen D. Transfusion-transmitted HBV infection in an endemic area: the necessity of more sensitive screening for HBV carriers. Transfusion 2002, 42:1592-1597.
108. Eastlund T. Hemodilution due to blood loss and transfusion and reliability of cadaver infectious disease testing. Cell Tissue Bank 2000, 1:121-127.
109. Centre for Disease Control and Prevention, Human immunodeficiency virus infection transmitted from an organ donor screened for HIV antibody - North Carolina. MMWR 1987, 36:306-308.
110. Adams M., Lee T.H., Busch M.P., Heitman J., Marsh G.J., Gjerset G.F., Mosely J.W. Rapid freezing of whole blood or buffy coat sample for polymerase chain reaction and cell culture analysis: application to detection of human immunodeficiency virus in blood donor and recipient repositories. Transfusion 1993, 33:504-508.
111. Comeau A.M., Harris J., McIntosh K., Weiblen B.J., Hoff R., Grady G.F. Polymerase chain reaction in detecting HIV infection among seropositive infants: relation to clinical status and age and to results of other assays. J. Acquir. Immun. Defic. Syndr 1992, 5:271-278.
112. Busch M.P., Wilber J.C., Johnson P., Tobler L., Evans C.S. Impact of specimen handling and storage on detection of hepatitis C virus RNA. Transfusion 1992, 33:420-425.
113. Centre for Disease Control and Prevention, Ochrobactrium anthropi meningitis associated with cadaveric pericardial tissue processed with a contaminated solution - Utah, 1994. MMWR 1995, 45:671-673.
114. Farrington M., Matthews I., Foreman J., Caffrey E. Bone graft contamination from a water de-ionizer during processing in a bone bank. J. Hosp. Infect 1996, 32:61-64.
115. Hawkins A.E., Zuckerman M.A., Briggs M., Gilson R.J., Goldstone A.H., Brink N.S., Tedder R.S. Hepatitis B nucleotide sequence analysis: linking an outbreak of acute hepatitis b to contamination of a cryopreservation tank. Virol. Methods 1996, 60:81-88.
116. Strong D., Eastlund T., Mowe J. Tissue bank activity in the United States - 1992. Report of annual registration of AATB inspected tissue banks. Tissue Cell Rep 1995, 3:8-10.
117. Pruss A., Hansen A., Kao M., Gurtler L., Paul G., Benedix F., Von Versen R. Comparison of the efficacy of virus inactivation methods in allogeneic avital bone tissue transplants. Cell Tissue Bank 2001, 2:201-215.